U.S. General Merchandise and Department Stores Stock News

Fresh interest in Luckin Coffee (OTCPK:LKNC.Y) has been triggered by recent analyst coverage highlighting higher earnings estimates and a top Zacks Rank. This has drawn attention to how the stock’s current pricing compares with those expectations. Over the past month Luckin Coffee has delivered a 30 day share price return of about 10%, although the share price has eased in the last week and is now at US$35.25. The 1 year total shareholder return is slightly negative and the 5 year total...

Corvus Pharmaceuticals recently reported in Blood the final peer-reviewed Phase 1/1b data for its oral ITK inhibitor soquelitinib in advanced T cell lymphomas, showing durable responses, a median overall survival exceeding two years, and a favorable safety profile across multiple dose levels. The publication strengthens the scientific case for soquelitinib’s selective ITK inhibition and Th1-skewing mechanism, underpinning Corvus’s ongoing registration Phase 3 PTCL trial and broader...

Why Novanta’s strong quarter matters for shareholders now Novanta (NOVT) posted quarterly revenue that exceeded analyst expectations and issued EBITDA and revenue guidance above forecasts. Yet the stock has slipped since the report, which hints that investor expectations were already high. Over the past year, Novanta’s share price has moved sharply higher, with a year-to-date share price return of 30.15% and a 1-year total shareholder return of 22.51%. However, the 9.21% share price decline...

In recent days, Leidos Holdings, Inc. announced two new U.S. defense health and cyber contracts: a US$301,000,000, five-year Army network monitoring agreement and a US$56,000,000, 66‑month Naval Health Research Center award for behavioral health research and operational assessments. Together, these wins highlight how Leidos is tying advanced AI-enabled cyber defense with data-driven psychological health work, deepening its role in supporting military readiness across both digital and human...

In recent days, analysts have revised their earnings estimates higher for Everus Construction Group, Inc. (NYSE: ECG), reflecting increased optimism about the company’s earnings outlook. This broad-based shift in expectations, paired with a top-tier Zacks Rank #1 (Strong Buy), suggests analysts see its earnings power differently than before. With analysts increasingly aligned in raising earnings estimates, we’ll now examine how this improved sentiment interacts with Everus Construction...

Valero Energy (VLO) attracted fresh attention after its second quarter 2026 results showed a large improvement in adjusted earnings per share and revenues, along with a top Zacks Rank based on expected earnings growth. Against this backdrop, Valero Energy’s share price has climbed to $346.59, supported by a 30 day share price return of 15.96% and a 90 day share price return of 41.57%. The 1 year total shareholder return of 134.15% shows how strong the recent momentum has been despite a small...

Workday (NasdaqGS: WDAY) and Salary.com announced a certified integration that automates compensation data management for joint customers. The integration connects Workday Human Capital Management with Salary.com to synchronize job, employee, and pay data for compensation teams. Customers gain a direct link between internal compensation management and external market pricing data to support pay decisions. Early adoption from financial services firms highlights immediate interest from sectors...

Chemed stock performance snapshot after recent price moves Chemed (CHE) has drawn fresh attention after recent price moves, with the stock last closing at US$520.27. That level reflects mixed short term returns and a stronger picture over the past 3 months. Over the past year Chemed has delivered a 15.74% total shareholder return. The recent 1 day share price move down 5.16% to US$520.27 contrasts with a 22.01% 90 day share price return, suggesting momentum has cooled slightly after a strong...

Recently, Celsius Holdings reported weaker-than-expected second-quarter earnings, prompting several brokerages including Deutsche Bank, Bernstein, and Maxim to downgrade the energy drink maker due to concerns over softer core brand trends and a longer recovery timeline into fiscal 2027. This clash between cautious analyst revisions and earlier optimism about Celsius’ growth and profitability potential highlights how sensitive the company’s valuation is to shifts in earnings...

Shopify stock has delivered a strong 3 year return, yet several valuation checks now suggest the shares trade at a premium to what the company’s current cash flow profile and fundamentals may justify. Both a Discounted Cash Flow (DCF) intrinsic value estimate and market multiple comparisons point in the same direction, which puts the recent share price strength under the spotlight for investors. Over the past 3 years, Shopify has returned about 132.1% which puts extra focus on whether...

Franklin Templeton recently paid a quarterly cash dividend of US$0.33 per share on October 9, 2026, to shareholders of record on September 30, 2026, matching the prior quarter’s payout and reflecting a 3.1% increase over the same quarter a year earlier. Separately, HashKey Holdings Limited announced a collaboration under which HashKey Exchange will distribute Franklin Templeton’s tokenized Franklin OnChain U.S. Government Liquidity Fund (grBENJI) to eligible digital asset investors in Asia,...

Vulcan Materials has delivered a solid 55.7% total return over the past 5 years, yet current valuation checks suggest the stock is trading at a premium to its estimated intrinsic value. Both cash flow based and market multiple assessments currently point to Vulcan Materials looking expensive rather than like an obvious bargain. The 55.7% gain over 5 years indicates that long-term holders have already captured a significant portion of the value on offer from Vulcan Materials. Future pricing...

Earlier in August, Steel Dynamics’ board declared a third-quarter cash dividend of US$0.53 per share, payable on or about October 9, 2026, to shareholders of record as of September 30, 2026. This dividend affirmation comes alongside analyst expectations for stronger earnings and potential benefits from proposed U.S. tariffs on Canadian steel and vehicles, which together highlight how policy and payout decisions may influence the company’s outlook. Now we’ll examine how the proposed 50%...

Recent Share Price Moves and What They Mean for Camden Property Trust Camden Property Trust (CPT) has drawn attention after its share price closed at US$105.79, with returns down about 2% over the past week and 8% over the past month. Investors are weighing these moves against the company’s recent financial trends. Looking beyond the recent pullback, Camden Property Trust’s share price return has slipped over the past month, while the year to date move is more modest and the one year total...

FirstEnergy earnings beat puts Energize365 investments in focus FirstEnergy (FE) recently reported second quarter 2026 adjusted earnings of $0.50 per share, topping estimates and drawing investor attention to how its capital plan and transmission projects might shape the stock. The company also reaffirmed its 2026 core earnings guidance and confirmed plans to invest $6b under its Energize365 program. That update, together with progress on new generation and solar projects, gives investors...

In recent days, Cognex Corporation has seen analysts raise their earnings estimates for upcoming quarters and the full year, reflecting stronger expectations for its financial performance. This wave of upward revisions has also improved its ranking in third-party rating systems that focus on earnings estimate trends, highlighting a shift in sentiment among covering analysts. Next, we’ll examine how these upward earnings estimate revisions may influence Cognex’s existing investment narrative...

Hims & Hers Health (HIMS) is back in focus after regulators accused the telehealth company of deceptive subscription practices and improper sharing of sensitive health data. This has prompted fresh questions around legal risk and customer trust. Against this regulatory backdrop, Hims & Hers Health’s share price has been volatile, with a 1-day share price return of 6.13% but a year-to-date share price return that is down 5.24%. The 3-year total shareholder return of about 3.7x indicates that...

Quanta Services (PWR) drew fresh attention after the Quanta Services tokenized stock on Robinhood reached its all time high on 27 August 2026, highlighting renewed interest in exposure to the underlying shares. Over the past year, momentum in Quanta Services has been strong, with the share price at $621.83 and a year-to-date share price return of 41.43%. The 1-year total shareholder return of 61.25% and 5-year total shareholder return of 449.60% point to a stock where long-term holders have...

AES stock has delivered a weak overall result over the past five years, yet several valuation checks now suggest the current share price may sit below what its cash flows imply. The question for investors is whether AES is a genuine value opportunity or simply reflecting the challenges embedded in its recent track record. The share price is down about 26.4% over the last five years, which points to a period where long term holders have not been rewarded. Expectations for future cash...

Why the ALKIVIA results matter for Zai Lab stock Zai Lab (ZLAB) stock action is currently anchored to fresh clinical data from the ALKIVIA Phase 3 trial of VYVGART Hytrulo in autoimmune myositis, which met its primary endpoint with statistically significant results. The study showed a 15.4 point greater improvement in Total Improvement Score at Week 52 versus placebo in the combined immune mediated necrotizing myopathy and dermatomyositis population, with benefits emerging by Week 4 and...

AXT stock has delivered an extremely strong run over the past few years, yet the latest valuation checks suggest the shares now lean expensive rather than offering clear value. After such a sharp move, investors are weighing the recent gains against what the broader valuation signals and fundamentals imply for risk and reward. Over the past 3 years, AXT has returned about 24x, which puts a spotlight on how much future growth is already reflected in the share price. Expectations that higher...

Acadia Pharmaceuticals has received European Commission marketing authorization for DAYBU (trofinetide) to treat neurobehavioral symptoms of Rett syndrome in patients aged five and older across the European Union, Iceland, Liechtenstein, and Norway, based on Phase 3 LAVENDER data showing statistically significant and clinically meaningful improvements on key clinical scales. This approval makes DAYBU the first and only authorized therapy for Rett syndrome in the EU, potentially opening a new...

Guidewire Software recently reported earnings for the quarter ended July 2026, delivering year-over-year growth in both earnings and revenue after earlier caution from analysts. The negative Earnings ESP ahead of the release highlighted growing analyst uncertainty, making the subsequent earnings call a focal point for understanding business conditions and expectations. With mixed analyst sentiment highlighted by the negative Earnings ESP, we’ll now examine how this earnings setup shapes...

Plug Power stock has delivered a very weak long term result, with the share price down about 91.6% over the past 5 years. However, current valuation checks still point to an expensive profile rather than a clear bargain. Recent price gains and ongoing news around project cancellations and funding challenges keep attention on whether the current market value matches the company’s risk and return trade off. Over 5 years, Plug Power shares have fallen about 91.6%, which signals that long term...